Abstract Details

Title Brain Arteriovenous Malformations: Outcome after Interventional Versus Conservative Management. Prospective Study of 302 Patients

Topic Cerebrovascular Disease and Interventional Neurology

Presentation(s) (-)

Poster/Presentation
Number 055

Objective

Background

Design/Methods

Results

Conclusions

Authors/Disclosures
Carlos Cantu, MD, MSc (Hospital Angeles Del Pedregal)	Dr. Cantu has nothing to disclose.
Alberto Mimenza, MD	No disclosure on file
	No disclosure on file
	No disclosure on file
	No disclosure on file
Adam De Havenon, MD, FAAN (Yale University)	Dr. De Havenon has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Novo Nordisk. Dr. De Havenon has or had stock in Certus.Dr. De Havenon has or had stock in TitinKM. The institution of Dr. De Havenon has received research support from NIH/NINDS. Dr. De Havenon has received publishing royalties from a publication relating to health care.

��ɫ��